{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:20:34Z","timestamp":1789410034239,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00520-025-09293-0","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:42:22Z","timestamp":1743892942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A systematic review and meta-analysis of side effects influenced by non-surgical treatments in African cancer patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Omolola","family":"Salako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Y.","family":"Habeebu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Okediji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaorah F.","family":"Enyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehinde S.","family":"Okunade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel T.","family":"Fagbenro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blossom A.","family":"Maduafokwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oghenekome O.","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamaldeen","family":"Abdulraheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Allsop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"9293_CR1","unstructured":"WHO. (n.d.). Cancer. Retrieved April 25, 2024, from https:\/\/www.afro.who.int\/health-topics\/cancer. Accessed 13 Nov\u00a02024"},{"key":"9293_CR2","unstructured":"Dattani SD, Spooner F, Ritchie H, Roser M (2023) Causes of death. [Internet]. Our World in Data; 2023 Dec 15. Available from: https:\/\/ourworldindata.org\/causes-of-death. Accessed 25 Apr 2024"},{"key":"9293_CR3","doi-asserted-by":"publisher","unstructured":"Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, Ali Z, Anderson, BO, Anorlu R, Avery S, Barango P, Bih N, Booth CM, Brawley OW, Dangou JM, Denny L, Dent J, Elmore SNC, Elzawawy A, \u2026 Kerr D (2022) Cancer in sub-Saharan Africa: a Lancet Oncology Commission. Lancet Oncol 23(6), e251\u2013e312. https:\/\/doi.org\/10.1016\/S1470-2045(21)00720-8","DOI":"10.1016\/S1470-2045(21)00720-8"},{"key":"9293_CR4","unstructured":"The Global Cancer Observatory (GLOBOCAN). (n.d.) Statistics at a glance 2022 Retrieved April 25, 2024, from https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/903-africa-fact-sheet.pdf"},{"issue":"11","key":"9293_CR5","doi-asserted-by":"publisher","first-page":"e0225039","DOI":"10.1371\/JOURNAL.PONE.0225039","volume":"14","author":"P Ssentongo","year":"2019","unstructured":"Ssentongo P, Lewcun JA, Candela X, Ssentongo AE, Kwon EG, Ba DM, Oh JS, Amponsah-Manu F, McDonald AC, Chinchilli VM, Soybel DI, Dodge DG (2019) Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: a systematic review and meta-analysis. PLoS ONE 14(11):e0225039. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0225039","journal-title":"PLoS ONE"},{"issue":"2","key":"9293_CR6","doi-asserted-by":"publisher","first-page":"i","DOI":"10.4172\/1948-5956.100000E2","volume":"1","author":"A Sudhakar","year":"2009","unstructured":"Sudhakar A (2009) History of cancer, ancient and modern treatment methods. J Cancer Sci Ther 1(2):i\u2013iv. https:\/\/doi.org\/10.4172\/1948-5956.100000E2","journal-title":"J Cancer Sci Ther"},{"issue":"9","key":"9293_CR7","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/S00520-022-07044-Z","volume":"30","author":"A Donkor","year":"2022","unstructured":"Donkor A, Atuwo-Ampoh VD, Yakanu F, Torgbenu E, Ameyaw EK, Kitson-Mills D, Vanderpuye V, Kyei KA, Anim-Sampong S, Khader O, Khader J (2022) Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis. Supportive Care Cancer\u202f: Official J Multinational Assoc Supportive Care Cancer 30(9):7159\u20137190. https:\/\/doi.org\/10.1007\/S00520-022-07044-Z","journal-title":"Supportive Care Cancer : Official J Multinational Assoc Supportive Care Cancer"},{"issue":"6","key":"9293_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/J.MCNA.2017.06.003","volume":"101","author":"N Gegechkori","year":"2017","unstructured":"Gegechkori N, Haines L, Lin JJ (2017) Long-term and latent side effects of specific cancer types. Med Clin North Am 101(6):1053\u20131073. https:\/\/doi.org\/10.1016\/J.MCNA.2017.06.003","journal-title":"Med Clin North Am"},{"key":"9293_CR9","doi-asserted-by":"publisher","unstructured":"Nabieva N, Fehm T, H\u00e4berle L, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Popovic M, \u2026 Fasching PA (2018) Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: results of the prospective EvAluate-TM study. European J Cancer (Oxford, England\u202f: 1990) 96 82\u201390 https:\/\/doi.org\/10.1016\/J.EJCA.2018.03.020","DOI":"10.1016\/J.EJCA.2018.03.020"},{"issue":"12","key":"9293_CR10","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1007\/S00520-020-05705-5","volume":"28","author":"AG Blidner","year":"2020","unstructured":"Blidner AG, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Anderson R (2020) Cancer immunotherapy-related adverse events: causes and challenges. Supportive Care Cancer\u202f: Official J Multinational Assoc Supportive Care Cancer 28(12):6111\u20136117. https:\/\/doi.org\/10.1007\/S00520-020-05705-5","journal-title":"Supportive Care Cancer : Official J Multinational Assoc Supportive Care Cancer"},{"key":"9293_CR11","unstructured":"National Cancer Institute. (n.d.). Financial toxicity and cancer treatment. Retrieved January 30, 2025, from https:\/\/www.cancer.gov\/about-cancer\/managing-care\/track-care-costs\/financial-toxicity-hp-pdq. Accessed 30 Jan 2025"},{"key":"9293_CR12","doi-asserted-by":"publisher","first-page":"1111677","DOI":"10.3389\/FRHS.2023.1111677\/BIBTEX","volume":"3","author":"O Abdelhadi","year":"2023","unstructured":"Abdelhadi O (2023) The impact of psychological distress on quality of care and access to mental health services in cancer survivors. Front Health Serv 3:1111677. https:\/\/doi.org\/10.3389\/FRHS.2023.1111677\/BIBTEX","journal-title":"Front Health Serv"},{"issue":"6","key":"9293_CR13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/CANCERS16061117\/S1","volume":"16","author":"R Mansour","year":"2024","unstructured":"Mansour R, Abdel-Razeq H, Al-Hussaini M, Shamieh O, Al-Ibraheem A, Al-Omari A, Mansour AH (2024) Systemic barriers to optimal cancer care in resource-limited countries: Jordanian Healthcare as an Example. Cancers 16(6):1117. https:\/\/doi.org\/10.3390\/CANCERS16061117\/S1","journal-title":"Cancers"},{"issue":"15","key":"9293_CR14","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1158\/1078-0432.CCR-09-0344","volume":"15","author":"PH O\u2019Donnell","year":"2009","unstructured":"O\u2019Donnell PH, Dolan ME (2009) Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy. Clinical Cancer Res\u202f: An Official J American Assoc Cancer Res 15(15):4806\u20134814. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0344","journal-title":"Clinical Cancer Res : An Official J American Assoc Cancer Res"},{"issue":"10","key":"9293_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/J.JCLINEPI.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1\u2013e34. https:\/\/doi.org\/10.1016\/J.JCLINEPI.2009.06.006","journal-title":"J Clin Epidemiol"},{"key":"9293_CR16","doi-asserted-by":"publisher","unstructured":"Wang, N. (2023). Conducting meta-analyses of proportions in R. J Behavioral Data Sci 3(2), 64\u2013126 https:\/\/doi.org\/10.35566\/JBDS\/V3N2\/WANG","DOI":"10.35566\/JBDS\/V3N2\/WANG"},{"key":"9293_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CMAR.S386181","volume":"15","author":"M Dessalegn","year":"2023","unstructured":"Dessalegn M, Tsegaye A, Fantahun M, Yesufe AA, Hussein M (2023) Chemotherapy induced neutropenia, febrile-neutropenia and determinants among solid cancer patients attending oncology unit of a tertiary care teaching hospital in Ethiopia. Cancer Manag and Res 15:185\u2013195. https:\/\/doi.org\/10.2147\/CMAR.S386181","journal-title":"Cancer Manag and Res"},{"issue":"1","key":"9293_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/S12887-023-03891-9\/TABLES\/6","volume":"23","author":"WO Tola","year":"2023","unstructured":"Tola WO, Melaku T, Fufa D, Sheleme T (2023) Adverse drug events and contributing factors among pediatric cancer patients at Jimma University Medical Center Southwest Ethiopia. BMC Pediatrics 23(1):77. https:\/\/doi.org\/10.1186\/S12887-023-03891-9\/TABLES\/6","journal-title":"BMC Pediatrics"},{"issue":"8","key":"9293_CR19","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1111\/BCP.15659","volume":"90","author":"VA Nyangwara","year":"2024","unstructured":"Nyangwara VA, Mazhindu T, Chikwambi Z, Masimirembwa C, Campbell TB, Borok M, Ndlovu N (2024) Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. Br J Clin Pharmacol 90(8):1782\u20131789. https:\/\/doi.org\/10.1111\/BCP.15659","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"9293_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/AAM.AAM_87_20","volume":"21","author":"KM Manyega","year":"2022","unstructured":"Manyega KM, Joseph BN, Rotkangmwa OC, Dapar MP (2022) Chemotherapy-associated nausea and vomiting: a cross-sectional survey of occurrence and management patterns at Jos University Teaching Hospital Nigeria. Ann Afr Med 21(2):124\u2013131. https:\/\/doi.org\/10.4103\/AAM.AAM_87_20","journal-title":"Ann Afr Med"},{"issue":"24","key":"9293_CR21","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2217\/FON-2022-0116","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W, Azibani F, Libhaber E, Okello E, Kayima J, Ssinabulya I, Leeta J, Orem J, Sliwa K (2022) Detecting subclinical anthracycline therapy-related cardiac dysfunction in patients attending Uganda Cancer Institute. Future Oncol 18(24):2675\u20132685. https:\/\/doi.org\/10.2217\/FON-2022-0116","journal-title":"Future Oncol"},{"key":"9293_CR22","unstructured":"Robert M. Strother. (2021). Intravenous chemotherapy or oral chemotherapy in treating patients with previously untreated stage III-IV HIV-associated non-Hodgkin lymphoma. https:\/\/clinicaltrials.gov\/study\/NCT01775475?tab=history"},{"issue":"1","key":"9293_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12885-021-08567-0\/FIGURES\/5","volume":"21","author":"J Paken","year":"2021","unstructured":"Paken J, Govender CD, Pillay M, Ayele BT, Sewram V (2021) Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa. BMC Cancer 21(1):1\u201311. https:\/\/doi.org\/10.1186\/S12885-021-08567-0\/FIGURES\/5","journal-title":"BMC Cancer"},{"issue":"1","key":"9293_CR24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4314\/AHS.V19I1.40","volume":"19","author":"S Kibudde","year":"2019","unstructured":"Kibudde S, Mondo CK, Kibirige D, Walusansa V, Orem J (2019) Anthracycline induced cardiotoxicity in adult cancer patients: a prospective cohort study from a specialized oncology treatment centre in Uganda. Afr Health Sci 19(1):1647. https:\/\/doi.org\/10.4314\/AHS.V19I1.40","journal-title":"Afr Health Sci"},{"issue":"2","key":"9293_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4314\/REJHS.V7I2.2","volume":"7","author":"BA Ayoade","year":"2019","unstructured":"Ayoade BA, Salami BA, Oritogun KS, Fatungase OM, Ebili HO, Adekoya AO (2019) Response to neoadjuvant chemotherapy in breast cancer in a resource limited environment. Res J Health Sci 7(2):82\u201390. https:\/\/doi.org\/10.4314\/REJHS.V7I2.2","journal-title":"Res J Health Sci"},{"key":"9293_CR26","doi-asserted-by":"publisher","unstructured":"Dano D, H\u00e9non C, Sarr O, Ka K, Ba M, Badiane A, Thiam I, Diene P, Diop M, Dem A, Marino P, Mancini J, Annede P, Gon\u00e7alves A, Diouf D, and Monneur A (2019) Quality of life during chemotherapy for breast cancer in a West African population in Dakar, Senegal: a prospective study. J Global Oncol 5(5), JGO.19.00106. https:\/\/doi.org\/10.1200\/JGO.19.00106","DOI":"10.1200\/JGO.19.00106"},{"key":"9293_CR27","doi-asserted-by":"publisher","unstructured":"Hassen AM, Taye G, Gizaw M, and Hussien FM (2019) Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. PloS One 14(9) https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0222629","DOI":"10.1371\/JOURNAL.PONE.0222629"},{"issue":"5","key":"9293_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/TBJ.12149","volume":"19","author":"OA Arowolo","year":"2013","unstructured":"Arowolo OA, Njiaju UO, Ogundiran TO, Abidoye O, Lawal OO, Obajimi M, Adetiloye AV, Im HK, Akinkuolie AA, Oluwasola A, Adelusola K, Kayode AA, Agbakwuru AE, Oduntan H, Babalola CP, Fleming G, Olopade OC, Falusi AG, Durosinmi MA, Olopade OI (2013) Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study. Breast J 19(5):470. https:\/\/doi.org\/10.1111\/TBJ.12149","journal-title":"Breast J"},{"issue":"2","key":"9293_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000227021","volume":"49","author":"WR Bezwoda","year":"1992","unstructured":"Bezwoda WR, Seymour L, Ariad S (1992) High-dose etoposide in treatment of metastatic breast cancer. Oncology 49(2):104\u2013107. https:\/\/doi.org\/10.1159\/000227021","journal-title":"Oncology"},{"key":"9293_CR30","doi-asserted-by":"publisher","unstructured":"Ketiku KK, and Ajekigbe AT (1990) Chemotherapy of breast cancer in Nigerians: side-effects and quality of life. Clinical Oncology (Royal College of Radiologists (Great Britain)), 2(3), 153\u2013155 https:\/\/doi.org\/10.1016\/S0936-6555(05)80149-9","DOI":"10.1016\/S0936-6555(05)80149-9"},{"issue":"1","key":"9293_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/MPO.2950140105","volume":"14","author":"WR Bezwoda","year":"1986","unstructured":"Bezwoda WR, Nissenbaum M, Derman DP (1986) Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate. Med Pediatr Oncol 14(1):17\u201319. https:\/\/doi.org\/10.1002\/MPO.2950140105","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"9293_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/MPO.2950140107","volume":"14","author":"WR Bezwoda","year":"1986","unstructured":"Bezwoda WR (1986) Treatment of advanced ovarian cancer: a randomised trial comparing Adriamycin or 4\u2019epi-Adriamycin in combination with cisplatin and cyclophosphamide. Med Pediatr Oncol 14(1):26\u201329. https:\/\/doi.org\/10.1002\/MPO.2950140107","journal-title":"Med Pediatr Oncol"},{"key":"9293_CR33","doi-asserted-by":"publisher","unstructured":"Gad-El-Mawla N, Macdonald JS, and Khaled H (1984) Hexamethylmelamine in advanced head and neck cancer. A phase II study. American J Clin Oncol 7(3) 205\u2013208. https:\/\/doi.org\/10.1097\/00000421-198406000-00003","DOI":"10.1097\/00000421-198406000-00003"},{"key":"9293_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/DHPS.S254644","volume":"12","author":"G Workalemahu","year":"2020","unstructured":"Workalemahu G, Abdela OA, Yenit MK (2020) Chemotherapy-related adverse drug reaction and associated factors among hospitalized paediatric cancer patients at hospitals in north-west Ethiopia. Drug, Healthcare Patient Safety 12:195\u2013205. https:\/\/doi.org\/10.2147\/DHPS.S254644","journal-title":"Drug, Healthcare Patient Safety"},{"key":"9293_CR35","doi-asserted-by":"publisher","unstructured":"Kuguyo O, Matimba A, Madziyire MG, Magwali T, Dandara C, Nhachi CFB, and Tsikai N (2024) Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer. Future Oncology (London, England), 20(26). https:\/\/doi.org\/10.1080\/14796694.2024.2375959","DOI":"10.1080\/14796694.2024.2375959"},{"issue":"1","key":"9293_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1186\/S12885-024-12987-Z","volume":"24","author":"JN Oenga","year":"2024","unstructured":"Oenga JN, Tamukong R, Isiiko J, Gibu SG, Gidion K, Yadesa TM (2024) Prevalence, classifications and factors associated with sexual dysfunction among adult cancer patients on chemotherapy at the Uganda Cancer Institute Mbarara. BMC Cancer 24(1):1209. https:\/\/doi.org\/10.1186\/S12885-024-12987-Z","journal-title":"BMC Cancer"},{"key":"9293_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/DHPS.S116924","volume":"8","author":"SA Belachew","year":"2016","unstructured":"Belachew SA, Erku DA, Mekuria AB, Gebresillassie BM (2016) Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar University Referral Hospital, Ethiopia: a cross-sectional study. Drug, Healthcare Patient Safety 8:83\u201390. https:\/\/doi.org\/10.2147\/DHPS.S116924","journal-title":"Drug, Healthcare Patient Safety"},{"key":"9293_CR38","doi-asserted-by":"publisher","unstructured":"Joseph A, Akinsete A, Adeneye S, Balogun O, Awofeso O, Oladipo A, Ajose A, Elhamamsi I, Merrell K, Ngwa W, Puthoff D, Shour AR, and Onitilo A (2023) Feasibility and safety of implementing volumetric arc therapy (VMAT) for pediatric craniospinal irradiation in a low-middle-income region: the Nigerian experience. Adv Radiation Oncol 9(2). https:\/\/doi.org\/10.1016\/J.ADRO.2023.101325","DOI":"10.1016\/J.ADRO.2023.101325"},{"key":"9293_CR39","doi-asserted-by":"publisher","unstructured":"Salako O, Okunade KS, Adeniji AA, Fagbenro GT, and Afolaranmi OJ (2021) Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria. Ecancermedicalscience 15 https:\/\/doi.org\/10.3332\/ECANCER.2021.1188","DOI":"10.3332\/ECANCER.2021.1188"},{"key":"9293_CR40","doi-asserted-by":"publisher","unstructured":"Ahmed Shaaban MH, Elbaiomy MA, Eltantawy A, El-Gilany Abdel-Fattah AH, and Shamaa, SSA (2024) Comparing ribociclib versus palbociclib as a second line treatment in combination with fulvestrant in metastatic breast cancer: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention\u202f: APJCP, 25(9), 3039\u20133049. https:\/\/doi.org\/10.31557\/APJCP.2024.25.9.3039","DOI":"10.31557\/APJCP.2024.25.9.3039"},{"key":"9293_CR41","doi-asserted-by":"publisher","unstructured":"El-Zeiny A, Abdelfatah R, Abbassi M, Farid SF (2024) idarubicin versus doxorubicin in acute myeloid leukemia: a parallel randomized trial with pharmacoeconomic analysis. Pharm Sci 30(1):135\u2013142. https:\/\/doi.org\/10.34172\/PS.2023.28","DOI":"10.34172\/PS.2023.28"},{"issue":"1","key":"9293_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/S12905-022-02003-6","volume":"22","author":"DH Mvunta","year":"2022","unstructured":"Mvunta DH, August F, Dharsee N, Mvunta MH, Wangwe P, Ngarina M, Simba BM, Kidanto H (2022) Quality of life among cervical cancer patients following completion of chemoradiotherapy at Ocean Road Cancer Institute (ORCI) in Tanzania. BMC Women\u2019s Health 22(1):426. https:\/\/doi.org\/10.1186\/S12905-022-02003-6","journal-title":"BMC Women\u2019s Health"},{"issue":"3","key":"9293_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/10781552231178297","volume":"30","author":"A Degu","year":"2024","unstructured":"Degu A, Karimi PN, Opanga SA, Nyamu DG (2024) Drug-related problems among esophageal, gastric and colorectal cancer patients at the national and referral hospital in Kenya. J Oncol Pharmacy Practice\u202f: Official Publication Int Soc Oncol Pharmacy Practitioners 30(3):493\u2013506. https:\/\/doi.org\/10.1177\/10781552231178297","journal-title":"J Oncol Pharmacy Practice : Official Publication Int Soc Oncol Pharmacy Practitioners"},{"issue":"7","key":"9293_CR44","doi-asserted-by":"publisher","first-page":"e29003","DOI":"10.1002\/PBC.29003","volume":"68","author":"D Moyo","year":"2021","unstructured":"Moyo D, Chimalizeni Y, Chagaluka G, Banda CG, Molyneux EM (2021) Early doxorubicin cardiotoxicity in Malawian children admitted to Queen Elizabeth Central Hospital Malawi. Pediatric Blood Cancer 68(7):e29003. https:\/\/doi.org\/10.1002\/PBC.29003","journal-title":"Pediatric Blood Cancer"},{"issue":"15_suppl","key":"9293_CR45","doi-asserted-by":"publisher","first-page":"11569","DOI":"10.1200\/JCO.2021.39.15_SUPPL.11569","volume":"39","author":"E Kasonkanji","year":"2021","unstructured":"Kasonkanji E, Gondwe Y, Dewey M, Gumulira J, Painschab M, Hosseinipour M, Dittmer D (2021) Prospective cohort study of Kaposi sarcoma treated under real-world conditions in Malawi. J Clin Oncol 39(15_suppl):11569\u201311569. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_SUPPL.11569","journal-title":"J Clin Oncol"},{"key":"9293_CR46","doi-asserted-by":"publisher","unstructured":"Ben Ayed W, Ben Said A, Hamdi A, Mokrani A, Masmoudi Y, Toukabri I, Limayem I, and Yahyaoui Y (2020) Toxicity, risk factors and management of cisplatin-induced toxicity: a prospective study, 26(7) 1621\u20131629. https:\/\/doi.org\/10.1177\/1078155219901305","DOI":"10.1177\/1078155219901305"},{"key":"9293_CR47","doi-asserted-by":"publisher","unstructured":"Gadisa DA, Assefa M, Tefera GM, and Yimer G (2020) Patterns of anthracycline-based chemotherapy-induced adverse drug reactions and their impact on relative dose intensity among women with breast cancer in Ethiopia: a prospective observational study. J Oncol 2020. https:\/\/doi.org\/10.1155\/2020\/2636514","DOI":"10.1155\/2020\/2636514"},{"issue":"7","key":"9293_CR48","doi-asserted-by":"publisher","first-page":"e0271877","DOI":"10.1371\/JOURNAL.PONE.0271877","volume":"17","author":"AK Arjarquah","year":"2022","unstructured":"Arjarquah AK, Obodai E, Anie HA, Osei MA, Odoom JK, Bonney JHK, Behene E, Kotey EN, Aboagye J, Nyarko SO, Bentum J, Yeboah C, Kumordjie S, Agbodzi B, Attiku K, Mawuli G, Letizia A, Ampofo WK, Quaye O (2022) Occurrence of influenza and bacterial infections in cancer patients receiving radiotherapy in Ghana. PLoS ONE 17(7):e0271877. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0271877","journal-title":"PLoS ONE"},{"issue":"3","key":"9293_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/JCLS.JCLS_85_19","volume":"17","author":"B Adegboyega","year":"2020","unstructured":"Adegboyega B, Muhammad H, Joseph A, Alabi B, Durosinmi-Etti F (2020) Prospective study on acute toxicities of external beam radiotherapy in the management of pelvic malignancies in Lagos University Teaching Hospital. J Clinical Sci 17(3):80. https:\/\/doi.org\/10.4103\/JCLS.JCLS_85_19","journal-title":"J Clinical Sci"},{"key":"9293_CR50","doi-asserted-by":"publisher","first-page":"102032","DOI":"10.1016\/J.TRANON.2024.102032","volume":"47","author":"KA Kyei","year":"2024","unstructured":"Kyei KA, Daniels J, Pratt-Ainooson F, Anim-Sampong S, Nkansah EO, Amoabeng KA, Antwi WK (2024) Incidence and severity of acute radiation induced toxicities among breast cancer patients treated with adjuvant radiotherapy at a major cancer treatment center in Ghana. Translational Oncol 47:102032. https:\/\/doi.org\/10.1016\/J.TRANON.2024.102032","journal-title":"Translational Oncol"},{"key":"9293_CR51","doi-asserted-by":"publisher","unstructured":"Grover S, George J, Tuli S, Lichter K, Bhatia R, Monare B, Chinniah G, Bazzett-Matabele L, Bvochora-Nsingo M, Chiyapo S, Balang D, Ralefala T, Vuylsteke P, Luckett R, Shin S, Zetola N, and Ramogola-Masire D (2022) Stage and outcomes of invasive cervical cancer patients in Botswana: a prospective cohort study from 2013 to 2020. Gynecol Oncol Rep 44 https:\/\/doi.org\/10.1016\/J.GORE.2022.101094","DOI":"10.1016\/J.GORE.2022.101094"},{"issue":"1","key":"9293_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/S00520-011-1110-3\/METRICS","volume":"20","author":"H Abbas","year":"2012","unstructured":"Abbas H, Bensadoun RJ (2012) Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck. Support Care Cancer 20(1):185\u2013190. https:\/\/doi.org\/10.1007\/S00520-011-1110-3\/METRICS","journal-title":"Support Care Cancer"},{"key":"9293_CR53","doi-asserted-by":"publisher","unstructured":"Adegboyega B, Joseph A, Alabi A, Omomila J, Ngema LM, Ainsworth V, Chin J, Evbuomwan MO, and Ngwa W (2023) Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center. BMC Cancer, 23(1) https:\/\/doi.org\/10.1186\/S12885-023-11675-8","DOI":"10.1186\/S12885-023-11675-8"},{"key":"9293_CR54","doi-asserted-by":"publisher","unstructured":"Degu A, Karimi PN, Opanga SA, and Nyamu DG (2023) Drug-related problems among esophageal, gastric and colorectal cancer patients at the national and referral hospital in Kenya. 30(3), 493\u2013506. https:\/\/doi.org\/10.1177\/10781552231178297","DOI":"10.1177\/10781552231178297"},{"key":"9293_CR55","doi-asserted-by":"publisher","unstructured":"Kibaara M, and Degu, A (2021) Assessment of adverse events among cervical cancer patients at Kenyatta National Hospital. 29(2), 326\u2013332. https:\/\/doi.org\/10.1177\/10781552211068133","DOI":"10.1177\/10781552211068133"},{"issue":"2","key":"9293_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/JCLS.JCLS_79_18","volume":"17","author":"A Sowunmi","year":"2020","unstructured":"Sowunmi A, Onuoha P, Alabi A, Okoro U (2020) Side effects of radiotherapy on breast cancer patients in the Department of Radiotherapy, Lagos University Teaching Hospital, Idi-Araba, Lagos Nigeria. J Clin Sci 17(2):30. https:\/\/doi.org\/10.4103\/JCLS.JCLS_79_18","journal-title":"J Clin Sci"},{"issue":"1","key":"9293_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.YGYNO.2019.01.023","volume":"153","author":"MH Einstein","year":"2019","unstructured":"Einstein MH, Ndlovu N, Lee J, Stier EA, Kotzen J, Garg M, Whitney K, Lensing SY, Tunmer M, Kadzatsa W, Palefsky J, Krown SE (2019) Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: a phase II study of the AIDS malignancy consortium. Gynecol Oncol 153(1):20\u201325. https:\/\/doi.org\/10.1016\/J.YGYNO.2019.01.023","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9293_CR58","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/J.IJROBP.2018.01.067","volume":"101","author":"S Grover","year":"2018","unstructured":"Grover S, Bvochora-Nsingo M, Yeager A, Chiyapo S, Bhatia R, MacDuffie E, Puri P, Balang D, Ratcliffe S, Narasimhamurthy M, Gwangwava E, Tsietso S, Kayembe MKA, Ramogola-Masire D, Dryden-Peterson S, Mahantshetty U, Viswanathan AN, Zetola NM, Lin LL (2018) Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting. Int J Radiat Oncol Biol Phys 101(1):201\u2013210. https:\/\/doi.org\/10.1016\/J.IJROBP.2018.01.067","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9293_CR59","doi-asserted-by":"publisher","unstructured":"SC, A., R, O., Oche, O., Z, J., U, I., CU, U., EC, A., SI, E., B, O., P, A., V, O., & T, I. (2017). Anaemia in cancer patients undergoing radiotherapy and chemotherapy at the national hospital, Abuja. J Neoplasm, 2(2). https:\/\/doi.org\/10.21767\/2576-3903.100012","DOI":"10.21767\/2576-3903.100012"},{"key":"9293_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/J.IJSU.2016.08.520","volume":"34","author":"BP Phakathi","year":"2016","unstructured":"Phakathi BP, Basson G, Karusseit VOL, Olorunju SAS, Mokoena T (2016) The effect of HIV infection on the surgical, chemo- and radiotherapy management of breast cancer. A prospective cohort study. Int J Surg (London, England) 34:109\u2013115. https:\/\/doi.org\/10.1016\/J.IJSU.2016.08.520","journal-title":"Int J Surg (London, England)"},{"issue":"4","key":"9293_CR61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/JPM13040588\/S1","volume":"13","author":"BL Afolabi","year":"2023","unstructured":"Afolabi BL, Mazhindu T, Zedias C, Borok M, Ndlovu N, Masimirembwa C (2023) Pharmacogenetics and adverse events in the use of fluoropyrimidine in a cohort of cancer patients on standard of care treatment in Zimbabwe. J Personalized Med 13(4):588. https:\/\/doi.org\/10.3390\/JPM13040588\/S1","journal-title":"J Personalized Med"},{"issue":"1","key":"9293_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12905-022-02041-0\/TABLES\/8","volume":"22","author":"M Aldaak","year":"2022","unstructured":"Aldaak M, Suliman HM, Abd-Elgadir EE, Abdoon IH (2022) Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital. BMC Women\u2019s Health 22(1):1\u201311. https:\/\/doi.org\/10.1186\/S12905-022-02041-0\/TABLES\/8","journal-title":"BMC Women\u2019s Health"},{"key":"9293_CR63","doi-asserted-by":"publisher","unstructured":"Aitelhaj M, Lkhoyaali S, Rais G, Boutayeb S, and Errihani H (2016) First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - observational institutional study. PAMJ 24(324) https:\/\/doi.org\/10.11604\/PAMJ.2016.24.324.4058","DOI":"10.11604\/PAMJ.2016.24.324.4058"},{"issue":"1","key":"9293_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.ACVDSP.2020.10.178","volume":"13","author":"R Benmalek","year":"2021","unstructured":"Benmalek R, Krikez I, Bendahou H, Maaroufi A, Abouriche A, Arous S, Azzouzi L, Habbal R, Haffadi M, Bourhafour M, Tawfik N, Benider A (2021) Assessment of cardiotoxicity in breast cancer patients in the first cardio-oncology unit in Morocco: about 1092 cases. Arch Cardiovasc Diseases Suppl 13(1):79. https:\/\/doi.org\/10.1016\/J.ACVDSP.2020.10.178","journal-title":"Arch Cardiovasc Diseases Suppl"},{"issue":"1","key":"9293_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.31557\/APJCP.2021.22.1.145","volume":"22","author":"AA Abdeltawab","year":"2021","unstructured":"Abdeltawab AA, Ali SA, Mostafa HG, Hassan MA (2021) Predictive factors increasing the risk of radiation toxicity in patients with early breast cancer. Asian Pacific J Cancer Prevention APJCP 22(1):145. https:\/\/doi.org\/10.31557\/APJCP.2021.22.1.145","journal-title":"Asian Pacific J Cancer Prevention APJCP"},{"issue":"3","key":"9293_CR66","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/S10549-022-06835-6\/METRICS","volume":"197","author":"OA Ayeni","year":"2023","unstructured":"Ayeni OA, Chiwambutsa S, Chen WC, Kapungu N, Kanji C, Thelingwani R, Murugan N, Mathiba R, Phakathi B, Nietz S, Ramiah D, O\u2019Neil DS, Jacobson JS, Ruff P, Cubasch H, Chirwa T, Joffe M, Masimirembwa C, Neugut AI (2023) The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Res Treat 197(3):647\u2013659. https:\/\/doi.org\/10.1007\/S10549-022-06835-6\/METRICS","journal-title":"Breast Cancer Res Treat"},{"key":"9293_CR67","doi-asserted-by":"publisher","unstructured":"Choulli F, Tafenzi HA, Hattimy, F. El, Choulli MK, and Belbaraka R (2024) Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study\u202f: Mohammed VI University Hospital, Medical Oncology Department, Marrakech, Morocco. BMC Cancer, 24(1) https:\/\/doi.org\/10.1186\/S12885-023-11616-5","DOI":"10.1186\/S12885-023-11616-5"},{"key":"9293_CR68","doi-asserted-by":"publisher","unstructured":"Moyo, D., Chimalizeni, Y., Chagaluka, G., Banda, C. G., & Molyneux, E. M. (2021). Early doxorubicin cardiotoxicity in Malawian children admitted to Queen Elizabeth Central Hospital, Malawi. Pediatric Blood Cancer, 68(7). https:\/\/doi.org\/10.1002\/PBC.29003","DOI":"10.1002\/PBC.29003"},{"key":"9293_CR69","doi-asserted-by":"publisher","unstructured":"Degu A, Karimi PN, Opanga SA, and Nyamu DG (2024) Health-related quality of life among patients with esophageal, gastric, and colorectal cancer at Kenyatta National Hospital. Cancer Reports (Hoboken, N.J.), 7(3). https:\/\/doi.org\/10.1002\/CNR2.2038","DOI":"10.1002\/CNR2.2038"},{"issue":"3","key":"9293_CR70","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/1440-1681.13036","volume":"46","author":"R Corremans","year":"2019","unstructured":"Corremans R, Ad\u00e3o R, De Keulenaer GW, Leite-Moreira AF, Br\u00e1s-Silva C (2019) Update on pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity. Clin Exp Pharmacol Physiol 46(3):204\u2013215. https:\/\/doi.org\/10.1111\/1440-1681.13036","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"9293_CR71","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/0360-3016(93)90541-3","volume":"27","author":"M Efraim Stein","year":"1993","unstructured":"Efraim Stein M, Lakier R, Kuten A, Spencer D, Ruff P, Bezwoda WR (1993) Radiation therapy in endemic (African) Kaposi\u2019s sarcoma. Int J Radiat Oncol Biol Phys 27(5):1181\u20131184. https:\/\/doi.org\/10.1016\/0360-3016(93)90541-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9293_CR72","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/BCTT.S81710","volume":"7","author":"TA Koulis","year":"2015","unstructured":"Koulis TA, Phan T, Olivotto IA (2015) Hypofractionated whole breast radiotherapy: current perspectives. Breast Cancer\u202f: Targets Ther 7:363. https:\/\/doi.org\/10.2147\/BCTT.S81710","journal-title":"Breast Cancer : Targets Ther"},{"key":"9293_CR73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1200\/JGO.19.00286\/SUPPL_FILE\/DS_JGO.19.00286.PDF","volume":"6","author":"J Leng","year":"2020","unstructured":"Leng J, Ntekim AI, Ibraheem A, Anakwenze CP, Golden DW, Olopade OI (2020) Infrastructural challenges lead to delay of curative radiotherapy in Nigeria. J Global Oncol 6:269\u2013276. https:\/\/doi.org\/10.1200\/JGO.19.00286\/SUPPL_FILE\/DS_JGO.19.00286.PDF","journal-title":"J Global Oncol"},{"issue":"2","key":"9293_CR74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/1115-1474.121099","volume":"20","author":"K Nwankwo","year":"2013","unstructured":"Nwankwo K, Dawotola D, Sharma V (2013) Radiotherapy in Nigeria: current status and future challenges. West African J Radiol 20(2):84. https:\/\/doi.org\/10.4103\/1115-1474.121099","journal-title":"West African J Radiol"},{"key":"9293_CR75","doi-asserted-by":"publisher","first-page":"1122388","DOI":"10.3389\/FPHAR.2023.1122388","volume":"14","author":"G Gaobotse","year":"2023","unstructured":"Gaobotse G, Venkataraman S, Brown PD, Masisi K, Kwape TE, Nkwe DO, Rantong G, Makhzoum A (2023) The use of African medicinal plants in cancer management. Front Pharmacol 14:1122388. https:\/\/doi.org\/10.3389\/FPHAR.2023.1122388","journal-title":"Front Pharmacol"},{"issue":"2","key":"9293_CR76","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1111\/AJCO.12329","volume":"13","author":"Y Pan","year":"2017","unstructured":"Pan Y, Yang K, Wang Y, Zhang L, Liang H (2017) Could yoga practice improve treatment-related side effects and quality of life for women with breast cancer? A systematic review and meta-analysis. Asia Pac J Clin Oncol 13(2):e79\u2013e95. https:\/\/doi.org\/10.1111\/AJCO.12329","journal-title":"Asia Pac J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09293-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T07:55:16Z","timestamp":1745567716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09293-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9293"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09293-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"356"}}